As the CEO of Galatea Bio, Carlos Bustamante is at the forefront of driving discoveries in healthcare by pairing genetic diversity with advanced data analytics. The company focuses on populations historically underrepresented in genetics research. Bustamante's role is crucial in leveraging the company's clinical network, biobank, and cutting-edge algorithms to discover and validate new tests, trea...